Mercury Laboratories [MERCURYLAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Mercury Laboratories Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mercury Laboratories Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mercury Laboratories Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 18.15 67.11 Mercury Laboratories Ltd.
Price-to-Book Ratio 1.54 10.82 Mercury Laboratories Ltd.
Debt-to-Equity Ratio 10.77 0.58 Divi's Laboratories Ltd.
PEG Ratio -1.11 4.63 Divi's Laboratories Ltd.
EV/EBITDA 10.44 48.63 Mercury Laboratories Ltd.
Profit Margin (TTM) 6.20% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 8.99% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 8.99% 29.65% Divi's Laboratories Ltd.
Return on Equity 5.87% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 4.23% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-50.39M $2.15B Divi's Laboratories Ltd.
Dividend Yield 0.82% 0.91% Divi's Laboratories Ltd.
1-Year Return -11.83% -0.43% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.12 16.18 Mercury Laboratories Ltd.
Enterprise Value $887.85M $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.17 15.86 Mercury Laboratories Ltd.
Gross Profit Margin (TTM) 61.64% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $635 $388 Mercury Laboratories Ltd.
Earnings per Share (Diluted) $39.30 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.44 0.19 Divi's Laboratories Ltd.

Mercury Laboratories Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

MERCURYLAB
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mercury Laboratories Ltd.-2.06%-2.39%-0.16%-5.13%-9.16%-9.32%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mercury Laboratories Ltd.-11.83%-5.41%16.63%72.97%2,064.80%2,064.80%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Mercury Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricMERCURYLABDIVISLAB
Market Information
Market Cap i₹855.84M₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i19253,443
90 Day Avg. Volume i59283,911
Last Close₹759.00₹6,608.50
52 Week Range₹620.55 - ₹976.00₹5,636.50 - ₹7,071.50
% from 52W High-22.23%-6.55%
All-Time High₹1,303.00 (Jan 08, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-41.75%-6.55%
Growth Metrics
Quarterly Revenue Growth-0.06%0.12%
Quarterly Earnings Growth-0.16%-0.01%
Financial Health
Profit Margin (TTM) i0.06%0.24%
Operating Margin (TTM) i0.09%0.30%
Return on Equity (TTM) i0.06%0.15%
Debt to Equity (MRQ) i10.770.58
Cash & Liquidity
Book Value per Share (MRQ)₹464.51₹580.95
Cash per Share (MRQ)₹23.55₹122.95
Operating Cash Flow (TTM) i₹-12,625,000₹19.67B
Levered Free Cash Flow (TTM) i₹31.45M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.82%0.91%
Last 12-Month Dividend i₹7.00₹60.00

Valuation & Enterprise Metrics Analysis: Mercury Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricMERCURYLAB (Apr 26, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.1567.11
Forward P/E iN/A53.75
PEG Ratio i-1.114.63
Price to Sales (TTM) i1.1216.18
Price to Book (MRQ) i1.5410.82
Market Capitalization
Market Capitalization i₹855.84M₹1.69T
Enterprise Value i₹887.85M₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.1715.86
Enterprise to EBITDA i10.4448.63
Risk & Other Metrics
Beta i0.440.19
Book Value per Share (MRQ) i₹464.51₹580.95

Financial Statements Comparison: Mercury Laboratories Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMERCURYLAB (2025)DIVISLAB (2025)
Revenue/Sales i751.01M93.25B
Cost of Goods Sold i289.16M38.70B
COGS % of Revenue i38.5%41.5%
Gross Profit i461.85M54.55B
Gross Margin i61.5%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i74.14M25.71B
Operating Margin i9.9%27.6%
EBITDA i109.74M33.19B
EBITDA Margin i14.6%35.6%
Pre-Tax Income i46.62M29.16B
Pre-Tax Income % of Revenue i6.2%31.3%
Income Tax i15.17M7.25B
Income Tax % of Revenue i2.0%7.8%
Net Income (Profit) i31.45M21.91B
Profit Margin i4.2%23.5%

Balance Sheet & Liquidity Metrics

MetricMERCURYLAB (2025)DIVISLAB (2025)
Cash & Equivalents i3.32M4.15B
Total Current Assets i401.60M100.81B
Total Current Assets % of Revenue i53.5%108.1%
Total Current Liabilities i150.76M14.52B
Total Current Liabilities % of Revenue i20.1%15.6%
Long-Term Debt i37.83M20.00M
Long-Term Debt % of Revenue i5.0%0.0%
Total Shareholders Equity i535.69M149.69B
Retained Earnings i86.56M134.00B
Retained Earnings % of Revenue i11.5%143.7%
Property, Plant & Equipment i85.40M3.19B

Cash Flow Statement Comparison

MetricMERCURYLAB (2025)DIVISLAB (2025)
Operating Cash Flow i-12.63M19.67B
Operating Cash Flow % of Revenue i-1.7%21.1%
Capital Expenditures i-90.40M-14.38B
Free Cash Flow i-50.39M2.15B
FCF Margin i-6.7%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMERCURYLABDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i1.20M265.47M
Float Shares i165,470117.72M
% Held by Insiders i86.33%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i13.67%19.31%

Dividend Analysis & Yield Comparison: Mercury Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricMERCURYLABDIVISLAB
Last 12-Month Dividend i₹7.00₹60.00
Last 12-Month Dividend Yield i0.82%0.91%
3-Year Avg Annual Dividend i₹4.67₹50.00
3-Year Avg Dividend Yield i0.43%0.70%
3-Year Total Dividends i₹14.00₹150.00
Ex-Dividend DateAug 06, 2025Jul 25, 2025